* Says it plans to pay annual cash dividend as 100 won per share for FY 2016, to shareholders recorded on Dec. 31
Dec 5 Cambian Group Plc, a behavioural health services provider, said it would sell its adult services business to a unit of Universal Health Services Inc for 377 million pounds ($478 million) in cash.
Dec 5 Biotechnology company ReNeuron Group Plc said its experimental stem cell therapy helped some patients improve motor functions in their arms in a mid-stage study after being disabled by stroke.
* Proposed disposal of adult services business for cash consideration of 377 million stg
* Says it signed co-development and commercialization agreement with Mochida Pharmaceutical Co Ltd on Dec. 5, regarding biosimilar of cancer treatment
No related earnings announcements are currently scheduled within the next 7 days.